Merck

Cubist sales force seen as potential boon for Merck intestinal drug
Yahoo/Reuters
Tue, 12/9/14 - 10:13 pm
Cubist Pharma
M&A
Merck
drug reps
Will Tetraphase Pharmaceuticals Be The Next Antibiotic-Maker To Be Acquired After Cubist Pharmaceuticals
Bidness Etc.
Tue, 12/9/14 - 11:40 am
Tetraphase Pharmaceuticals
Cubist Pharma
Merck
M&A
Merck says still plans Cubist purchase, despite patent setback
Yahoo/Reuters
Tue, 12/9/14 - 09:22 am
Merck
Cubist Pharma
patents
Cubicin
M&A
Cubist Barred From Blocking Generic Cubicin Beyond 2016
Bloomberg
Tue, 12/9/14 - 08:06 am
Cubist Pharma
Merck
Cubicin
antibiotics
Merck Triggers The Race to Replace Cubist
Forbes
Mon, 12/8/14 - 03:49 pm
Merck
Cubist Pharma
M&A
antibiotics
antibiotic resistance
The 7 Most Important Drug-Stock Lessons From This Weekend's Blood Cancer Meeting
TheStreet.com
Mon, 12/8/14 - 10:30 am
Agios Pharmaceuticals
Novartis
CAR-T
Celgene
Amgen
Merck
Bristol-Myers Squibb
Seattle Genetics
Sunesis
Merck buying Cubist Pharmaceuticals for $8.4 billion, will help address antibiotic resistance
Yahoo/AP
Mon, 12/8/14 - 08:07 am
Merck
Cubist Pharma
M&A
Data Investigating KEYTRUDA® (pembrolizumab), Merck’s Anti-PD-1 Therapy, in Patients with Classical Hodgkin Lymphoma Presented at ASH Annual Meeting
Yahoo/BusinessWire
Sun, 12/7/14 - 10:19 am
Merck
Keytruda
Hodgkin's lymphoma
Merck in talks to acquire Cubist for over $8 billion: Sources
CNBC
Sat, 12/6/14 - 12:37 am
Merck
Cubist Pharma
M&A
No serious side effects in Merck/Newlink Ebola vaccine test
Yahoo/Reuters
Tue, 12/2/14 - 08:05 am
Merck
NewLink Genetics
vaccines
ebola virus
Fresh from a $3.85B deal, biotech CEO sets sights on the next big thing
Fierce Biotech
Mon, 12/1/14 - 08:19 am
Ron Renaud
Merck
Idenix
RaNA
RNA
Merck buys rights to NewLink's experimental Ebola vaccine
Yahoo/Reuters
Mon, 11/24/14 - 09:37 am
Merck
NewLink
ebola virus
vaccines
M&A
New data fuels doctors' demands to rewrite U.S. heart guidelines
Reuters
Fri, 11/21/14 - 11:05 am
LDL cholesterol
heart disease
statins
Merck
Vytorin
AstraZeneca
Pfizer
Do The IMPROVE-IT Results Offer Promise For Anacetrapib, Another Merck Heart Drug?
Forbes
Fri, 11/21/14 - 10:26 am
Anacetrapib
Merck
IMPROVE-IT
Europe gives green light to AbbVie hepatitis C medicine, others
Yahoo/Reuters
Fri, 11/21/14 - 08:11 am
Europe
AbbVie
hepatitis C
dasabuvir
Sanofi
eliglustat
Novartis
secukinumab
Merck
Vorapaxar
Boehringer Ingelheim
nintedanib
NewLink in Talks With Merck on Producing Ebola Vaccine
Bloomberg
Thu, 11/20/14 - 04:38 pm
NewLink Genetics
Merck
ebola virus
vaccines
Vero
Pfizer-Merck cancer deal reduces likelihood of AZ merger
Pharmaphorum
Tue, 11/18/14 - 10:09 am
Pfizer
Merck
AstraZeneca
M&A
Long-Awaited Study Boosts Merck, Could Be Good News for Regeneron, Amgen
Barron's
Mon, 11/17/14 - 04:03 pm
Merck
Vytorin
Amgen
Regeneron
After Years Under Attack, Merck's Vytorin Proves Effective
Forbes
Mon, 11/17/14 - 09:03 am
Merck
Vytorin
A Day Of Reckoning Approaches For Merck And Its Critics
Forbes
Thu, 11/13/14 - 10:29 am
Merck
Zetia
Vytorin

Pages